Abstracts & Lectures
Abstract book
Asbtractbook2007-b.pdf
(235 Kb)
Main lecture presentations
Opening lecture
Impact of conjugate pneumococcal vaccine on pneumococcal pneumonia:implications for pandemic influenza preparedness.
Keith Klugman,Atlanta, USA
Klugman_1.pdf
(1514 Kb)
Physiology and pathogenicity factors of S. pneumoniae
Pneumococcal fratricide: possible impact on horizontal gene transfer and virulence.
Leiv Sigve Håvarstein, As, Norway
S.Havarstein.pdf
(4599 Kb)
Pneumococcal peptidoglycan hydrolases: from phage to bacteria (or vice versa).
Ernesto García,Madrid, Spain
Ernesto_Garcia.pdf
(1460 Kb)
Antimicrobial resistance of S. pneumoniae
A fresh look at the definition of susceptibilityof Streptococcus pneumoniae to beta-lactamantibiotics.
Daniel Musher,Houston, USA
D.Musher.pdf
(2221 Kb)
Update on macrolide resistance.
Josefina Liñares, Barcelona, Spain
J._linares.pdf
(324 Kb)
Resistance to fluoroquinolones and fitness cost.
Keith Klugman, Atlanta, USA
K.Klugman_2.pdf
(587 Kb)
Relationship between antimicrobial resistance and virulence.
Jefferey Weiser, Philadelphia, US
J.Weiser.pdf
(2353 Kb)
Clinical management and epidemiology of S. pneumoniae
Nasopharyngeal colonisation.
Helena Mäkelä, Helsinki, Finland
H._Makel.pdf
(239 Kb)
Serotypes replacement.
Ron Dagan, Beer-Sheva, Israel
R._Dagan.pdf
(47 Kb)
Vaccines.
Ake Örtqvist, Stockholm, Sweden
A._Ortqvist.pdf
(2327 Kb)
Treatment of multidrug resistant S. pneumoniae.
Javier Garau, Barcelona, Spain
J._Garau.pdf
(627 Kb)
